Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism

BACKGROUND: Treatment of severe diffuse congenital hyperinsulinism (CHI) without sufficient response to diazoxide is complicated by the lack of approved drugs. Therefore, patients are often hospitalized long-term or have to undergo pancreatic surgery if episodes of severe hypoglycaemia cannot be pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Corda, Heike, Kummer, Sebastian, Welters, Alena, Teig, Norbert, Klee, Dirk, Mayatepek, Ertan, Meissner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455078/
https://www.ncbi.nlm.nih.gov/pubmed/28576129
http://dx.doi.org/10.1186/s13023-017-0653-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455078/
https://www.ncbi.nlm.nih.gov/pubmed/28576129
http://dx.doi.org/10.1186/s13023-017-0653-x

Ejemplares similares